Press releases
* (R) = Regulatory press releases
Nov 4, 2026
(R) Cantargia Presents Promising Early Results with Nadunolimab in MDS and AML Ahead of ASH 2026
Sep 30, 2026
Cantargia Highlights Preclinical Data at AACR Supporting Nadunolimab in Combination with RAS Inhibition in PDAC
Aug 19, 2026